Monopar Therapeutics Inc (MNPR)
0.75
-0.01
(-1.68%)
USD |
NASDAQ |
May 08, 15:24
Monopar Therapeutics Cash from Operations (Quarterly): -1.546M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.546M |
| September 30, 2023 | -1.940M |
| June 30, 2023 | -2.102M |
| March 31, 2023 | -2.271M |
| December 31, 2022 | -1.302M |
| September 30, 2022 | -2.148M |
| June 30, 2022 | -1.311M |
| March 31, 2022 | -2.468M |
| December 31, 2021 | -2.032M |
| September 30, 2021 | -1.941M |
| June 30, 2021 | -1.406M |
| March 31, 2021 | -1.938M |
| December 31, 2020 | -1.241M |
| September 30, 2020 | -1.300M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.9955M |
| March 31, 2020 | -1.126M |
| December 31, 2019 | -0.6687M |
| September 30, 2019 | -0.6133M |
| June 30, 2019 | -0.7397M |
| March 31, 2019 | -0.996M |
| December 31, 2018 | -0.5192M |
| September 30, 2018 | -0.5996M |
| June 30, 2018 | -0.7529M |
| March 31, 2018 | -0.8088M |
| December 31, 2017 | -0.816M |
| September 30, 2017 | -1.195M |
| June 30, 2017 | -0.3051M |
| March 31, 2017 | -0.3115M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.468M
Minimum
Mar 2022
-0.6133M
Maximum
Sep 2019
-1.531M
Average
-1.406M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Motus GI Holdings Inc | -1.856M |
| SeaStar Medical Holding Corp | -4.485M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 3.471M |
| Xtant Medical Holdings Inc | -0.915M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.970M |
| Cash from Financing (Quarterly) | 0.3345M |
| Free Cash Flow | -7.858M |
| Free Cash Flow Per Share (Quarterly) | -0.1056 |
| Free Cash Flow Yield | -75.81% |